Participants in a primary care clinic or office with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis for whom the treatment with Simponi® by autoinjector device is to be initiated for the first time
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01313858?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
